Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Tactile Systems Technology, Inc is a medical devices business based in the US. Tactile Systems Technology shares (TCMD) are listed on the NASDAQ and all prices are listed in US Dollars. Tactile Systems Technology employs 707 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$51.19|
|52-week range||$30.31 - $64.53|
|50-day moving average||$50.44|
|200-day moving average||$53.27|
|Wall St. target price||$69.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.41|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||-0.02%|
|3 months (2021-05-05)||-5.38%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
Valuing Tactile Systems Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tactile Systems Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tactile Systems Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 25.4579. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tactile Systems Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Tactile Systems Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.5 million.
The EBITDA is a measure of a Tactile Systems Technology's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$186.2 million|
|Operating margin TTM||0.41%|
|Gross profit TTM||$133.2 million|
|Return on assets TTM||0.29%|
|Return on equity TTM||-1.33%|
|Market capitalisation||$967.4 million|
TTM: trailing 12 months
There are currently 1.6 million Tactile Systems Technology shares held short by investors – that's known as Tactile Systems Technology's "short interest". This figure is 3.7% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Tactile Systems Technology shares can be evaluated.
Tactile Systems Technology's "short interest ratio" (SIR) is the quantity of Tactile Systems Technology shares currently shorted divided by the average quantity of Tactile Systems Technology shares traded daily (recently around 112094.99314129). Tactile Systems Technology's SIR currently stands at 14.58. In other words for every 100,000 Tactile Systems Technology shares traded daily on the market, roughly 14580 shares are currently held short.
However Tactile Systems Technology's short interest can also be evaluated against the total number of Tactile Systems Technology shares, or, against the total number of tradable Tactile Systems Technology shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tactile Systems Technology's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Tactile Systems Technology shares in existence, roughly 80 shares are currently held short) or 0.0863% of the tradable shares (for every 100,000 tradable Tactile Systems Technology shares, roughly 86 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Tactile Systems Technology.
Find out more about how you can short Tactile Systems Technology stock.
We're not expecting Tactile Systems Technology to pay a dividend over the next 12 months.
Over the last 12 months, Tactile Systems Technology's shares have ranged in value from as little as $30.31 up to $64.53. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tactile Systems Technology's is 1.5898. This would suggest that Tactile Systems Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Tactile Systems Technology, Inc. , a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; and Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. .
Everything we know about the Chobani IPO, plus information on how to buy in.
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.